Xencor Inc (NASDAQ:XNCR)

36.91
Delayed Data
As of Sep 20
 +1.43 / +4.03%
Today’s Change
27.75
Today|||52-Week Range
46.65
+2.07%
Year-to-Date
No recent news for Xencor Inc.

Today’s Trading

Previous close35.48
Today’s open35.49
Day’s range35.25 - 37.44
Volume1,471,665
Average volume (3 months)482,031
Market cap$2.0B
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)-24.31%
Earnings growth (this year)+103.89%
Earnings growth (next 5 years)--
Revenue growth (last year)+13.70%
P/E ratio42.9
Price/Sales48.04
Price/Book3.82

Competitors

 Today’s
change
Today’s
% change
QUREUniqure NV-0.93-1.96%
XLRNAcceleron Pharma Inc-0.19-0.44%
ZLABZai Lab Ltd+0.48+1.40%
DCPHDeciphera Pharmaceut...+0.51+1.42%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$40.6M
Annual profit (last year)-$70.4M
Net profit margin-173.41%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Chief Financial Officer &
Senior Vice President
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts